Immunai vs Mybiotics Pharma
Immunai vs Mybiotics Pharma, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunai is on 69/100 and Mybiotics Pharma on 40/100.
Where each one leads
Immunai
- our overall score: 69/100 against 40/100
- domain rating: 46/100 against 33/100
- headcount: 179 against 12
- headcount growth: +13.0% against -24.1%
- funding raised: $295M against $12.3M
- LinkedIn following: 26,832 against 1,170
Mybiotics Pharma
- agent readiness: 42/100 against 32/100
At a glance
| Measure | Immunai | Mybiotics Pharma |
|---|---|---|
| What it is | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. | MyBiotics Pharma develops innovative microbiome-based pharmabiotics and drugs using proprietary bacterial mixes and efficient delivery technologies. |
| Category | Healthcare, Immunology, Data, Analytics | Microbiome, Therapeutics, Gastroenterology, Bacteria |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2019 | 2014 |
| Headquarters | New York, United States | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Immunai | Mybiotics Pharma |
|---|---|---|
| Employees | 179 | 12 |
| Headcount growthLast 12 months | +13.0% | -24.1% |
| Total funding | $295M | $12.3M |
| Latest round | Series B | Grant |
| Valuation | $1.0B | Not published |
| LinkedIn followers | 26,832 | 1,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunai | Mybiotics Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 40/100 |
| Traction | 60/100 | 47/100 |
| Team | 70/100 | Not published |
| Search visibility | 39/100 | 26/100 |
| Quality | 78/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 33/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunai | Mybiotics Pharma |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Not detected |
Immunai vs Mybiotics Pharma: common questions
Which is better, Immunai or Mybiotics Pharma?
On our 0-100 score Immunai rates higher (69/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Immunai and Mybiotics Pharma compare on the numbers?
Immunai leads on our overall score (69/100 against 40/100), domain rating (46/100 against 33/100), headcount (179 against 12), headcount growth (+13.0% against -24.1%), funding raised ($295M against $12.3M), LinkedIn following (26,832 against 1,170). Mybiotics Pharma leads on agent readiness (42/100 against 32/100).
Read the full Immunai review and pricing or the Mybiotics Pharma review and pricing. You can also browse other Immunai alternatives we track.

